Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $19.6000 (0.46%) ($19.1400 - $20.0000) on Fri. Aug. 23, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.79% (three month average) | RSI | 28 | Latest Price | $19.6000(0.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.4% a day on average for past five trading days. | Weekly Trend | IOVA declines -5.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(49%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -1.895% in a week (0% probabilities). VIXM(-28%) VXX(-15%) UUP(-9%) IFRA(-6%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.895% (StdDev 3.79%) | Hourly BBV | 0 () | Intraday Trend | 1.6% | | | |
|
1 - 5 Day Possible Target | $4.01(-79.54%) | Resistance Level | $21.78 | 5 Day Moving Average | $19.76(-0.81%) | 10 Day Moving Average | $20.31(-3.5%) | 20 Day Moving Average | $21.78(-10.01%) | To recent high | -24.6% | To recent low | 19.9% | Market Cap | $2.87b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |